Schizophyllan [9050-67-3]

Schizophyllan is an extracellular β-glucan synthesized by Schizophyllum commune. It improves mitochondrial function by activating the SIRT3 signaling pathway, thereby alleviating metabolic liver injury. Meanwhile, it inhibits JNK/p38 phosphorylation and downregulates the expression of PGC1β/PPARγ, c-Fos and NFATc1, thus suppressing osteoclast formation and promoting osteoblast differentiation. In addition, Schizophyllan enables targeted delivery of oligonucleotide drugs and antigens to antigen-presenting cells via Dectin-1-mediated recognition, showing broad application prospects in the treatment of inflammatory diseases and vaccine development.